Serum levels of Cu, CP, ATP7A/7B, and the Cu:Zn ratio in serum are result-related markers and are resistant to treatment across the entire spectrum of gastrointestinal tumours including gastric and oesophageal cancers [98,99,100,101]. This evidence concerns the gene ATP7A and digestive system neoplasm.